Evidence map›Paper›PMID 22815262›Full record

ArticleGenesis (New York, N.Y. : 2000)2012

Microarray analysis of Xenopus endoderm expressing Ptf1a.

Cassandra K Bilogan, Marko E Horb

Abstract read
In one paragraph

Article in Genesis (New York, N.Y. : 2000), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Xenopus as a Model for GI/Pancreas Disease.Current pathobiology reports · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Cassandra K BiloganBell Center for Regenerative Biology and Tissue Engineering, Marine Biological Laboratory, Woods Hole, Massachusetts, USA.
Marko E Horb
Brown University · US

Funding

Transcriptional Regulatory Networks Controlling Xenopus Pancreas DevelopmentR01DK077197 · NIDDK · MARINE BIOLOGICAL LABORATORY · PI HORB, MARKO E · 2007 to 2011
$1.1M
NIDDK NIH HHS DK077197NIDDK NIH HHS R01 DK077197
6 · The paper itself

Abstract

Pancreas-specific transcription factor 1a (Ptf1a), a bHLH transcription factor, has two temporally distinct functions during pancreas development; initially it is required for early specification of the entire pancreas, while later it is required for proper differentiation and maintenance of only acinar cells. The importance of Ptf1a function was revealed by the fact that loss of Ptf1a leads to pancreas agenesis in humans. While Ptf1a is one of the most important pancreatic transcription factors, little is known about the differences between the regulatory networks it controls during initial specification of the pancreas as opposed to acinar cell development, and to date no comprehensive analysis of its downstream targets has been published. In this article, we use Xenopus embryos to identify putative downstream targets of Ptf1a. We isolated anterior endoderm tissue overexpressing Ptf1a at two early stages, NF32 and NF36, and compared their gene expression profiles using microarrays. Our results revealed that Ptf1a regulates genes with a wide variety of functions, providing insight into the complexity of the regulatory network required for pancreas specification.

Indexed as

Gene Expression Regulation, DevelopmentalAnimalsBasic Helix-Loop-Helix ProteinsEndodermGene Expression ProfilingOligonucleotide Array Sequence AnalysisPancreasTranscription FactorsXenopus laevisXenopus ProteinsBasic Helix-Loop-Helix ProteinsPtf1a protein, Xenopustranscription factor PTF1Transcription FactorsXenopus Proteins

Identifiers

PMID22815262
PMCPMC3498591
OpenAlexW2053893375

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.